Zhongshan hospital, Fudan University
Shanghai, Shanghai Municipality, 200032, China
NCT Number: NCT03343496
Awake fibreoptic intubation (AFOI) is a classic and standard method for some special patients which is also difficult for anesthesiologists to learn and master. The procedure is sometimes hard and often takes about 20-30 min. Most of patients have a strong sense of discomfort. Investigators conducted the research to study the simplification and feasibility of AFOI.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200032, China
Many studies have studied the sedative drugs and regional anesthesia related to awake intubation. However, several problems of AFOI are existing including long operation time, patients' strong discomfort, coughing and resistance. And, to investigators' knowledge, there was a lack of a fixed procedure for the implementation of AFOI. Investigators conducted the research and aimed to study the simplification and feasibility of a new AFOI method based on years of clinical theory, practice and experience.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
With forty patients (ASA I~II, aged 18~75, simulating cervical instability injury) recruited to be operated on under general anesthesia, two experienced anesthesiologists performed the whole procedures within the study. Pre anesthetic interview was taken to illustrate the procedures of tracheal intubation to the patients. The simplified method consisted of three parts: conscious sedation, regional anesthesia and intubation. The time of AFOI, rate of one-time intubation success, hemodynamic parameters, pulse oxygen saturation (SpO2), rate of amnesia of the intubation, patients' satisfaction, and relative complications were recorded accordingly.
Time frame: End of the AFOI
The time from the midazolam injection to positive end tidal CO2 acquired (Minutes)
Time frame: End of the AFOI
All steps are successful once (Percentage)
Time frame: During the AFOI
SBP is used to assess hemodynamic fluctuations
Time frame: During the AFOI
DBP is used to assess hemodynamic fluctuations
Time frame: During the AFOI
HR is used to assess hemodynamic fluctuations
Time frame: On the first postoperative day
It is used to assess anterograde amnesia of midazolam
Time frame: During the AFOI
1= anxious or restless or both, 2 = cooperative, orientated and tranquil, 3 = responding to commands, 4 = brisk response to stimulus, 5 = sluggish response to stimulus, 6= No response to stimulus
Time frame: On the first postoperative day
1 = excellent, 2 = good, 3 = fair, 4 = poor
Time frame: During the AFOI
Unexpected coughing was evaluated with 4 score (1=none, 2< 3 times unexpected slight coughing comparable to 'clearing ones' throat', 3≥2 times, mild unexpected coughing lasting less than a minute, 4=persistent unexpected coughing)
Time frame: End of the surgery and the first postoperative day
Such as arrhythmias, bleeding or sore throat
Time frame: During the AFOI
1 = open, 2 = moving, 3 = closing, 4 = closed
Time frame: During the AFOI
SpO2<90%
Fudan University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06249659
Anesthesia, Complication,Postoperative
Clermont-Ferrand, France
View Trial DetailsNCT03277872
Anesthesia, Intubation
Montreal East, Quebec, Canada
View Trial DetailsNCT01823328
Airway Control, Anesthesia
Minneapolis, Minnesota, United States
View Trial DetailsNCT03709979
Anesthesia, Intubation
Malatya, Turkey (Türkiye)
View Trial Details